The list below is drawn from the FDA prescribing information for semaglutide [3] and tirzepatide [4], the 2023 Endocrine Society guideline [2], and the American Gastroenterological Association's 2022 clinical practice update on GLP-1 use in patients with gastrointestinal disease [5]
doi:10.1210/jcem-24-10-1076 53
Flag-IDA, An effective regimen for high risk AML
At its core, GHK-Cu functions as a matrikine, a signaling molecule released from the extracellular matrix when tissue damage occurs
Compact and easy to use, they enhance mental clarity, focus, and cardiovascular wellness, while supporting a healthy inflammatory response and overall blood sugar health
the localized repair-support component and the reason placement matters GHK-Cu Per mL 10 mg Per 20-unit dose 2.0 mg What it contributes Copper peptide signaling for collagen and elastin synthesis